CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Cigarette Smokingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07261176
NCT07261176N/ACompleted

Effect of Smoking on Retinal Vessel Morphology and Functionality: A Case-Control, Clinical Trial

IRCCS San Raffaele·interventional·Posted Dec 3, 2025·Updated Dec 3, 2025

In Brief

A clinical study evaluating Cigarette Smoking for Smokers. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The study aims at evaluating the effect of smoking activity on anatomy and functionality of retinal blood vessels using optical coherence tomography angiography (OCT-A) and dynamic vessel analysis (DVA). This is a low-risk, single-center, case-control, interventional clinical trial. Forty healthy subjects were enrolled: 20 healthy volunteers with regular daily tobacco activity (approximately 10 cigarettes per day for 5-10 years) and 20 healthy volunteers with no tobacco activity as controls. Each subject underwent comprehensive ophthalmologic examination including OCT-A, DVA, and retinal vessel analysis (RVA) at baseline. Examinations were repeated for the smoking group at 3 and 30 minutes after smoking activity, and for controls at 8 and 35 minutes after baseline to assess examination variability. The primary outcomes assessed changes in retinal perfusion and retinal vascular response after cigarette smoking compared to controls.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmokers
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 3, 2025
Enrollment StartApr 1, 2021
Primary CompletionDec 1, 2024
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 7 months ago

Interventions

Cigarette Smokingbehavioral

Participants smoked one cigarette containing 0.8 grams of nicotine under standardized conditions. Participants were required to abstain from tobacco activity for 24 hours prior to baseline examination and to avoid vasoconstrictor substances (coffee, alcohol) before examinations.